Filter Results:
(7,889)
Show Results For
- All HBS Web
(7,889)
- People (21)
- News (2,650)
- Research (4,138)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,377)
Show Results For
- All HBS Web
(7,889)
- People (21)
- News (2,650)
- Research (4,138)
- Events (21)
- Multimedia (297)
- Faculty Publications (3,377)
- July 2008 (Revised August 2008)
- Case
In-Vitro Fertilization: Outcomes Measurement
By: Michael E. Porter, Saquib Rahim and Benjamin Chung-Shi Tsai
As of 2007, there were very few examples of widespread measurement and reporting of health outcomes, a critical quality measure. In-vitro fertilization clinics have been required to report their patient's health outcomes since 1995. The protagonist of the case, Dr.... View Details
Keywords: Health Care and Treatment; Medical Specialties; Measurement and Metrics; Operations; Outcome or Result; Health Industry; Cleveland
Porter, Michael E., Saquib Rahim, and Benjamin Chung-Shi Tsai. "In-Vitro Fertilization: Outcomes Measurement." Harvard Business School Case 709-403, July 2008. (Revised August 2008.)
- September 2017
- Editorial
Helping Patients with Cancer Navigate Narrow Networks
By: Stephen M. Schleicher, Emeline M. Aviki and Thomas W. Feeley
The Affordable Care Act of 2010 (ACA) was designed primarily to improve patient access to affordable health care. The access-expanding provisions of the ACA included federal- and state-based health insurance exchanges with minimum coverage requirements and preexisting... View Details
Schleicher, Stephen M., Emeline M. Aviki, and Thomas W. Feeley. "Helping Patients with Cancer Navigate Narrow Networks." Journal of Clinical Oncology 35, no. 27 (September 2017): 3095–3096.
- August 2012 (Revised August 2012)
- Case
HealthAllies (A)
By: Regina E. Herzlinger and Michael Sherman
This case describes a "do good and do well" firm that enables individuals to buy health care services at discounted prices. It delineates the characteristics of the uninsured and others who are the primary targets for the firm. "HealthAllies (B)" provides information... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Marketing Channels; Demand and Consumers; Commercialization; Health Industry
Herzlinger, Regina E., and Michael Sherman. "HealthAllies (A)." Harvard Business School Case 302-019, August 2012. (Revised from original August 2001 version.)
- 18 Apr 2024
- Lecture
Innovation Opportunities Created by COVID-19 Can Help: And How to Make Them Happen
The crush of patients created by COVID enabled the creation of sites for care outside the traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by... View Details
- April 15, 2021
- Article
Remote Patient Monitoring—Overdue or Overused?
By: Keizra Mecklai, Nicholas Smith, Ariel Dora Stern and Daniel B. Kramer
As the use of remote patient monitoring services grows—driven by health care limitations imposed by the COVID-19 pandemic—clinicians, payers, and patients face important questions regarding the volume, value, and appropriate use of this care model. View Details
Mecklai, Keizra, Nicholas Smith, Ariel Dora Stern, and Daniel B. Kramer. "Remote Patient Monitoring—Overdue or Overused?" New England Journal of Medicine 384, no. 15 (April 15, 2021): 1384–1386.
- Program
Advanced Management Program
take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Alumni Status Upon completing the Advanced Management Program, you will become... View Details
- 02 Apr 2015
- Research & Ideas
Digital Summit Explores the New Economy
difficult to have innovation without data—which is one reason why the health care industry in the United States is too expensive. One remedy: Make the patient the customer. who Has The Power In The Music Industry? With inexpensive... View Details
Science Business: The Promise, the Reality, and the Future of Biotech
Why has the biotechnology industry failed to perform up to expectations despite all its promise? In Science Business, Professor Gary Pisano answers this question by providing an incisive critique of the industry. Pisano not only... View Details
Michael W. Toffel
Professor Toffel is the Senator John Heinz Professor of Environmental Management. His research examines how companies are addressing climate change (especially decarbonization) and other environmental and working condition issues in their operations and supply... View Details
- 25 Apr 2022
- Video
IFC Intro: GEO
- 02 Feb 2016
- News
HBS Launches Clinical Trials Contest
- March–April 2024
- Article
How Fast Should Your Company Really Grow?
By: Gary P. Pisano
Growth—in revenues and profits—is the yardstick by which the competitive fitness and health of organizations is measured. Consistent profitable growth is thus a near universal goal for leaders—and an elusive one.
To achieve that goal, companies need a growth... View Details
To achieve that goal, companies need a growth... View Details
Keywords: Growth and Development Strategy; Growth Management; Business Growth and Maturation; Business Strategy; Organizational Culture
Pisano, Gary P. "How Fast Should Your Company Really Grow?" Harvard Business Review 102, no. 2 (March–April 2024): 38–45.
- 25 Jul 2019
- Blog Post
Advancing a More Sustainable World with an MBA/MPA-ID
was my work with a power plant, the UN Framework Convention for Climate Change, or local county governments, financial returns often superseded the "green value" of projects. I quickly learned that beyond health or environmental... View Details
- January 2023
- Case
Natura: Weathering the Pandemic at Brazil's Cosmetic Giant
By: Brian Trelstad, Pedro Levindo and Carla Larangeira
Brazil's Natura, a multi-brand cosmetics group, has taken several measures to safeguard the livelihoods of its thousands of employees and millions of sales representatives during the COVID-19 health and economic crisis. The company has also made strides in its efforts... View Details
Keywords: COVID-19 Pandemic; ESG Reporting; Acquisition; Customer Focus and Relationships; Decision Making; Social Entrepreneurship; Environmental Sustainability; Environmental Management; Climate Change; Ethics; Moral Sensibility; Values and Beliefs; Global Strategy; Corporate Governance; Health Pandemics; Human Resources; Human Capital; Crisis Management; Growth and Development Strategy; Marketing; Distribution Channels; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Culture; Customer Ownership; Relationships; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Science-Based Business; Reputation; Human Needs; Social Issues; Strategy; Equality and Inequality; Beauty and Cosmetics Industry; Brazil; Latin America
- 22 Oct 2020
- News
What I wish I’d known at the start of the pandemic
- Article
A Blueprint for Pharmacy Benefits Managers to Increase Value
By: William Shrank, Michael E. Porter, Sachin H. Jain and Niteesh K. Choudhary
Pharmacy benefits managers (PBMs) have a unique opportunity to promote public health and generate value in the healthcare system. However, PBMs are largely evaluated on their ability to control costs rather than improve health. PBMs should be evaluated along three... View Details
Keywords: Opportunities; Health; System; Cost Management; Partners and Partnerships; Motivation and Incentives; Value; Innovation and Invention; Performance Effectiveness; Health Industry; Health Industry
Shrank, William, Michael E. Porter, Sachin H. Jain, and Niteesh K. Choudhary. "A Blueprint for Pharmacy Benefits Managers to Increase Value." American Journal of Managed Care 15, no. 2 (February 2009).
- August 2016 (Revised August 2016)
- Teaching Note
Intrapreneurship at DaVita Healthcare Partners
By: Joseph B. Fuller and Matthew Preble
DaVita Healthcare Partners Inc. (DaVita) is one of the U.S.'s leading dialysis providers, a process whereby persons with end-stage renal disease (ESRD) are connected to a machine that performs the functions of a healthy kidney. Kent Thiry, DaVita's CEO, has expanded... View Details